Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease

Chang Shang-Hung; Wu Chien-Chia V.; Yeh Yung-Hsin; Kuo Chang-Fu; Chen Yu-Ling; Wen Ming-Shien; See Lai-Chu; Huang Yu-Tung

首页> 外文期刊>The American Journal of Medicine >Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease

【24h】

Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease

机译：口腔抗凝血剂在心房颤动和阶段4或5阶段慢性肾病的患者中的疗效和安全性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PURPOSE: The aim of this study was to investigate whether oral anticoagulants can provide efficacy and safety profiles better than no anticoagulant in patients with stages 4 or 5 chronic kidney disease and atrial fibrillation.

机译：目的：本研究的目的是调查口腔抗凝血剂是否可以在4或5次慢性肾病和心房颤动的患者中没有抗凝血剂提供功效和安全性。

著录项

来源
《The American Journal of Medicine》 |2019年第11期|共15页
作者
Chang Shang-Hung; Wu Chien-Chia V.; Yeh Yung-Hsin; Kuo Chang-Fu; Chen Yu-Ling; Wen Ming-Shien; See Lai-Chu; Huang Yu-Tung;
展开▼
作者单位

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Mem Hosp Div Rheumatol Allergy &

Immunol Taoyuan Taiwan;

Chang Gung Mem Hosp Ctr Big Data Analyt &

Stat 15 Wunhua 1st Rd Taoyuan 333 Taiwan;

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Univ Coll Med Dept Publ Hlth Taoyuan Taiwan;

Chang Gung Mem Hosp Ctr Big Data Analyt &

Stat 15 Wunhua 1st Rd Taoyuan 333 Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Atrial fibrillation; Chronic kidney disease; Nonvitamin K antagonist oral anticoagulants; Warfarin;

机译：心房颤动;慢性肾病;非毒素K拮抗剂口腔抗凝剂;华法林;

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease [J] . Chang Shang-Hung, Wu Chien-Chia V., Yeh Yung-Hsin, The American Journal of Medicine . 2019,第11期

机译：口腔抗凝血剂在心房颤动和阶段4或5阶段慢性肾病的患者中的疗效和安全性
2. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease [J] . Bhatia Harpreet S., Bailey Joseph, Unlu Ozan, PACE: Pacing and clinical electrophysiology . 2019,第11期

机译：心房颤动和慢性肾病患者直接口服抗凝血剂的功效和安全性
3. Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease [J] . V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, Racional?naa Farmakoterapia v Kardiologii . 2019,第4期

机译：在心房颤动和慢性肾病患者中使用直接口服抗凝血剂的安全性
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Components of Oral Health in End-Stage Chronic Kidney Disease Patients Undergoing Chronic Dialysis Treatment [D] . Nenova-Nogalcheva, Anna. 2018

机译：口腔健康组分在接受慢性透析治疗的慢性肾病患者中的口腔健康
6. Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease [O] . Mihai Ciprian Stoica, Zsolt Gáll, Mirela Liana Gliga, 2021

机译：心房颤动患者口腔抗凝治疗和慢性肾病
7. Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease [O] . V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, 2019

机译：在心房颤动和慢性肾病患者中使用直接口服抗凝血剂的安全性

Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅